The management of malignant pleural mesothelioma in the USA 2004-13-a decade of lost opportunity?

about

The management of malignant pleural mesothelioma in the USA 2004-13-a decade of lost opportunity?

Item

http://www.wikidata.org/entity/Q55339037

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The management of malignant pl ...... -a decade of lost opportunity?

@en

The management of malignant pl ...... -a decade of lost opportunity?

@nl

type

Item

label

The management of malignant pl ...... -a decade of lost opportunity?

@en

The management of malignant pl ...... -a decade of lost opportunity?

@nl

prefLabel

The management of malignant pl ...... -a decade of lost opportunity?

@en

The management of malignant pl ...... -a decade of lost opportunity?

@nl

P1476

The management of malignant pl ...... -a decade of lost opportunity?

@en

P2093

David A Waller

http://www.w3.org/2001/XMLSchema#string

P2860

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.

Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial.

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study.

Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma

Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.

Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival.

Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position.

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

P304

S1044-S1046

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2018.04.63

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 9

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29849196

http://www.w3.org/2001/XMLSchema#string

P932

5949425

http://www.w3.org/2001/XMLSchema#string